Canada· CA-DIN-02328003
CARDIOLITE
A other cardiovascular system diagnostic radiopharmaceuticals product containing tetrakis [cu(mibi)4]bf4, registered in Canada by LANTHEUS MI CANADA INC. The same ATC class is registered in 3 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Tetrakis [cu(mibi)4]bf4 is registered in 3 of 19 countries.
Countries holding a registration under ATC V09GX (other cardiovascular system diagnostic radiopharmaceuticals), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 1 of them publish a price we can compare per daily dose
Tetrakis [cu(mibi)4]bf4 · ATC V09GX
3 / 19 countries
- Canada
- Denmark
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- TETRAKIS [CU(MIBI)4]BF4
- Manufacturer
- LANTHEUS MI CANADA INC
- Country
- Canada (CA)
- ATC code
- V09GX
- ATC class
- Other cardiovascular system diagnostic radiopharmaceuticals
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under V09GX
Other cardiovascular system diagnostic radiopharmaceuticals, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ad59dd29-482c-4dc0-844f-00933cd092bc GET /v1/drugs/ad59dd29-482c-4dc0-844f-00933cd092bc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02328003",
"form": "POWDER FOR SOLUTION",
"class": "Radiopharmaceutical",
"routes": [
"INTRAVENOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "V09GX",
"schedule": [
"Schedule C"
],
"drug_code": "81349",
"strengths": [
"1 MG"
],
"ahfs_class": null,
"substances": [
"TETRAKIS [CU(MIBI)4]BF4"
],
"product_categorization": null
}See everything about tetrakis [cu(mibi)4]bf4.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.